[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE344023T1 - Transdermales therapeutisches pflaster mit capsaicin und seinen analogen - Google Patents

Transdermales therapeutisches pflaster mit capsaicin und seinen analogen

Info

Publication number
ATE344023T1
ATE344023T1 AT03005137T AT03005137T ATE344023T1 AT E344023 T1 ATE344023 T1 AT E344023T1 AT 03005137 T AT03005137 T AT 03005137T AT 03005137 T AT03005137 T AT 03005137T AT E344023 T1 ATE344023 T1 AT E344023T1
Authority
AT
Austria
Prior art keywords
capsaicin
analogues
transdermal therapeutic
therapeutic patch
application
Prior art date
Application number
AT03005137T
Other languages
English (en)
Inventor
Wendye R Robbins
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE344023T1 publication Critical patent/ATE344023T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT03005137T 1997-12-15 1998-12-08 Transdermales therapeutisches pflaster mit capsaicin und seinen analogen ATE344023T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/990,633 US6239180B1 (en) 1995-11-08 1997-12-15 Transdermal therapeutic device and method with capsaicin and capsaicin analogs

Publications (1)

Publication Number Publication Date
ATE344023T1 true ATE344023T1 (de) 2006-11-15

Family

ID=25536360

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03005137T ATE344023T1 (de) 1997-12-15 1998-12-08 Transdermales therapeutisches pflaster mit capsaicin und seinen analogen
AT98962908T ATE240723T1 (de) 1997-12-15 1998-12-08 Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98962908T ATE240723T1 (de) 1997-12-15 1998-12-08 Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen

Country Status (11)

Country Link
US (2) US6239180B1 (de)
EP (2) EP1316308B1 (de)
AT (2) ATE344023T1 (de)
CA (1) CA2314326C (de)
CY (1) CY1107582T1 (de)
DE (2) DE69814917T2 (de)
DK (2) DK1316308T3 (de)
ES (2) ES2196640T3 (de)
HK (1) HK1030853A1 (de)
PT (1) PT1039802E (de)
WO (1) WO1999030560A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
GB2355934B (en) * 1999-11-05 2003-11-05 Lohmann Gmbh & Co Kg Wound dressing
AUPQ622600A0 (en) * 2000-03-15 2000-04-06 Unisearch Limited Treatment and/or prevention of ocular pain
DE10056009A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung hyperämisierender Wirkstoffe
US8110217B2 (en) * 2001-08-13 2012-02-07 University Of Pittsburgh Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
AU2002323151A1 (en) * 2001-08-13 2003-03-03 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
JP2005508372A (ja) * 2001-11-02 2005-03-31 エラン コーポレーシヨン ピーエルシー 薬剤組成物
DK1539124T3 (en) * 2002-09-05 2018-10-08 Vanderbilt Royalty Sub L P : COMPOSITIONS AND KITS FOR REMOVAL OF BODY SURFACES
WO2004026262A2 (en) * 2002-09-23 2004-04-01 Verion, Inc. Abuse-resistant pharmaceutical compositions
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
EP1587506B1 (de) * 2002-12-18 2008-07-23 Algorx Verabreichung von capsaicinoiden
US20050019436A1 (en) * 2002-12-18 2005-01-27 Algorx Injectable capsaicin
US7235270B2 (en) 2003-03-10 2007-06-26 Mayeux Jerry V Pain balm
BRPI0409748A (pt) * 2003-04-08 2006-10-24 Algorx Pharmaceuticals Inc preparação e purificação de capsaicin sintetico
US7943166B2 (en) 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
RU2349315C9 (ru) * 2003-04-14 2010-02-27 Лтс Ломанн Терапи-Системе Аг Терапевтический пластырь с полисилоксановой матрицей, содержащей капсаицин
DE102004009904A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
JP5148271B2 (ja) * 2004-06-02 2013-02-20 ニューロジズエックス，インコーポレーテッド 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物
US7704522B2 (en) 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
EP1827405A2 (de) * 2004-11-24 2007-09-05 Algorx Pharmaceuticals, Inc. Capsaicinoid-gelformulierung und ihre verwendungen
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
CN101189000A (zh) * 2005-02-14 2008-05-28 纽罗吉斯克斯公司 Trpv1激动剂的递送装置
WO2006099541A2 (en) * 2005-03-15 2006-09-21 Richard Daniel Carliss Therapeutic wound care product
CA2602832A1 (en) * 2005-03-30 2006-10-05 Keith R. Bley Low-concentration capsaicin patch and methods for treating neuropathic pain
EA013056B1 (ru) * 2005-04-01 2010-02-26 Ньюроджесэкс, Инк. Масла капсаициноидов и способы их получения и применения
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
CA2720250C (en) 2008-04-04 2018-01-23 Forsight Labs, Llc Therapeutic device for pain management and vision
US8987328B2 (en) * 2008-10-30 2015-03-24 Trinity Laboratories, Inc. Esters of capsaicinoids as dietary supplements
WO2011050327A1 (en) 2009-10-23 2011-04-28 Forsight Labs Llc Corneal denervation for treatment of ocular pain
US8591025B1 (en) 2012-09-11 2013-11-26 Nexisvision, Inc. Eye covering and refractive correction methods for LASIK and other applications
WO2011050365A1 (en) 2009-10-23 2011-04-28 Forsight Labs, Llc Conformable therapeutic shield for vision and pain
JP2013544132A (ja) 2010-10-25 2013-12-12 ネクシスビジョン， インコーポレイテッド 視力のための眼被覆物を特定するための方法および装置
WO2012149056A1 (en) 2011-04-28 2012-11-01 Nexisvision, Inc. Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
US9423632B2 (en) 2012-04-20 2016-08-23 Nexisvision, Inc. Contact lenses for refractive correction
CN104010635A (zh) 2011-09-09 2014-08-27 Api起源有限责任公司 包含trpv1选择性激动剂的止痛组合物及其制备和应用
US9465233B2 (en) 2012-04-20 2016-10-11 Nexisvision, Inc. Bimodular contact lenses
SG11201407322QA (en) 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of multiple sclerosis
CA2873096A1 (en) 2012-05-23 2013-11-28 Cellixbio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
CA2916885A1 (en) 2013-06-26 2014-12-31 Nexisvision, Inc. Contact lenses for refractive correction
US9341864B2 (en) 2013-11-15 2016-05-17 Nexisvision, Inc. Contact lenses having a reinforcing scaffold
WO2015116559A1 (en) 2014-01-29 2015-08-06 Nexisvision, Inc. Multifocal bimodulus contact lenses
WO2015160941A1 (en) 2014-04-15 2015-10-22 Vizuri Health Sciences Llc Topical compositions for pain relief, manufacture and use
NZ736131A (en) 2014-09-26 2019-04-26 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy and neurological disorders
SG11201702554QA (en) 2014-09-29 2017-04-27 Cellix Bio Private Ltd Compositions and methods for the treatment of multiple sclerosis
CA2965449C (en) 2014-10-27 2020-11-10 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
WO2016067297A1 (en) 2014-10-27 2016-05-06 Cellix Bio Private Limited Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
AU2015356569A1 (en) 2014-12-01 2017-06-29 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
JP6698669B2 (ja) 2015-02-09 2020-05-27 セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 粘膜炎の治療のための組成物及び方法
US10898537B2 (en) 2015-07-31 2021-01-26 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
KR20190039723A (ko) 2016-08-11 2019-04-15 셀릭스 바이오 프라이빗 리미티드 과민성 장 증후군의 치료용 조성물 및 방법
EP3522873B1 (de) 2016-10-04 2022-03-16 Cellix Bio Private Limited Zusammensetzungen und verfahren zur behandlung von xerostomie
WO2018115984A1 (en) 2016-12-19 2018-06-28 Cellix Bio Private Limited Compositions and methods for the treatment of inflammation
WO2019023605A1 (en) 2017-07-27 2019-01-31 Allergan, Inc. PROSTACYCLINE RECEPTOR AGONISTS FOR BODY GREASE REDUCTION
RU2761436C1 (ru) 2017-11-17 2021-12-08 Целликс Био Прайвет Лимитед Композиции и способы лечения нарушений со стороны органа зрения
JP7038437B2 (ja) 2017-11-17 2022-03-18 セリックス バイオ プライヴェート リミテッド 眼障害及び皮膚疾患の処置のための化合物、組成物、及び方法
CA3175582A1 (en) 2020-03-17 2021-09-23 Grunenthal Gmbh Repeated topical application of capsaicin patch for treating initial non-responders
BR112022020000A2 (pt) 2020-04-03 2022-11-22 Gruenenthal Gmbh Regime para aplicação tópica repetida de emplastro de capsaicina
RU2755206C1 (ru) 2020-05-20 2021-09-14 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство пролонгированного анальгетического действия и лекарственный препарат на его основе
US11234947B2 (en) * 2020-06-30 2022-02-01 Imperial College Innovations Limited Treatment of peripheral neuropathy induced by cancer chemotherapy

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486450B1 (en) 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4313958A (en) 1980-10-24 1982-02-02 The Procter & Gamble Company Method of producing analgesia
US4424205A (en) 1982-03-18 1984-01-03 The Procter & Gamble Company Hydroxyphenylacetamides having analgesic and anti-irritant activity
US4536404A (en) 1983-06-16 1985-08-20 Dermatological Enterprises, Ltd. Method and composition for treating post-herpetic neuralgia
US4544669A (en) 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4532139A (en) 1983-07-14 1985-07-30 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4544668A (en) 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4592912A (en) 1983-10-31 1986-06-03 Harriet Nickolaus Ache and pain relieving and preventing composition
US4681897A (en) 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4898887A (en) * 1984-12-20 1990-02-06 The Procter & Gamble Company Compounds and compositions having anti-inflammatory and analgesic activity
US4971800A (en) 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US4939149A (en) 1988-10-24 1990-07-03 The United States Of America As Represented By The Department Of Health And Human Services Resiniferatoxin and analogues thereof to cause sensory afferent C-fiber and thermoregulatory desensitization
US4997853A (en) 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5411738A (en) 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
CA1338779C (en) 1989-03-17 1996-12-10 Harry Hind Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
WO1990014083A1 (en) 1989-05-15 1990-11-29 Afferon Corporation Composition and method for neural desensitization
US5063060A (en) 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
JP2748199B2 (ja) * 1991-08-27 1998-05-06 泰一郎 岩倉 気管支喘息発作の予防と治療貼付剤
US5260313A (en) 1992-03-12 1993-11-09 National Pain Institute, Inc. Diagnosis and treatment of various neuralgias
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
JP3414423B2 (ja) * 1992-11-27 2003-06-09 積水化学工業株式会社 眠気防止用外用剤及び貼付剤
US5665360A (en) 1993-05-14 1997-09-09 Mann; Richard H. Method of treating peripheral neuropathies of the feet and legs
US5910512A (en) 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
DE4414502A1 (de) * 1994-04-26 1995-11-02 Edda Scholten Salbe zur äußerlichen Anwendung bei Schmerzen
US5665378A (en) 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5788982A (en) 1995-06-16 1998-08-04 Nadoolman; Wolffe Method and composition for treating oral pain using capsaicin
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US5856361A (en) 1996-04-23 1999-01-05 Medical Merchandising, Inc. Pain reliever and method of use
US5854291A (en) 1996-04-23 1998-12-29 Medical Merchandising, Inc. Pain reliever and method of use
US5869533A (en) 1996-04-23 1999-02-09 Holt; Stephen D. Non-irritating capsaicin formulations and applicators therefor
EP0998288B2 (de) 1997-03-13 2005-08-03 CAMPBELL, James, N. Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika
JP2002503451A (ja) 1998-01-22 2002-02-05 ザ・レジェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア カプサイシン受容体をコードする核酸配列
PT1056458E (pt) 1998-02-24 2005-08-31 Univ Wake Forest Tratamento de dor cronica

Also Published As

Publication number Publication date
DK1316308T3 (da) 2007-03-05
DE69814917D1 (de) 2003-06-26
EP1039802B1 (de) 2003-05-21
EP1039802A4 (de) 2002-01-23
US6239180B1 (en) 2001-05-29
ATE240723T1 (de) 2003-06-15
EP1316308A1 (de) 2003-06-04
DK1039802T3 (da) 2003-09-22
ES2272827T3 (es) 2007-05-01
CA2314326C (en) 2008-11-18
US20010002406A1 (en) 2001-05-31
DE69836352D1 (de) 2006-12-14
PT1039802E (pt) 2003-10-31
HK1030853A1 (en) 2001-05-25
ES2196640T3 (es) 2003-12-16
EP1316308B1 (de) 2006-11-02
CY1107582T1 (el) 2013-03-13
CA2314326A1 (en) 1999-06-24
WO1999030560A1 (en) 1999-06-24
EP1039802A1 (de) 2000-10-04
DE69836352T2 (de) 2007-05-24
DE69814917T2 (de) 2004-02-12

Similar Documents

Publication Publication Date Title
ATE344023T1 (de) Transdermales therapeutisches pflaster mit capsaicin und seinen analogen
EP1201241B8 (de) Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
GEP20002146B (en) Therapeutic Peptide Derivatives
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DE69213814D1 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69739050D1 (de) Verwendung von Thrombopoietin als Medikament zur Therapie und Vorbeugung der Thrombocytopenie
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
WO1998001563A3 (en) Adenovirus e4 proteins for inducing cell death
ATE200617T1 (de) Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
NO995944D0 (no) Anti-arrytmisk blanding og fremgangsmåter for behandling
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
DE69110615D1 (de) Verwendung von Aminosäuren zum Schutz von ischemischem Herzgewebe und dessen metabolischer Wiederherstellung.
CY1108368T1 (el) Διαδερμικη συσκευη φελοδιπινης και μεθοδοι
RU95122262A (ru) Способ лечения повреждений периферических нервов при травмах конечностей

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1316308

Country of ref document: EP